Extra-anorectic actions of mazindol

Area of Science:

• Pharmacology
• Gastroenterology
• Metabolic studies

Background:

• Mazindol is known for its weight-reducing effects.
• The precise mechanisms underlying mazindol's efficacy require further elucidation.
• Investigating metabolic and gastrointestinal effects can provide insights into its action.

Purpose of the Study:

• To investigate the influence of mazindol on thermogenesis, lipolysis, and gastric emptying in women.
• To determine if metabolic changes or delayed gastric emptying contribute to mazindol's weight-reducing properties.

Main Methods:

• Indirect calorimetry and blood glycerol measurements assessed thermogenesis and lipolysis.
• Gastric emptying (GE) was evaluated using a radiolabeled solid meal and gamma camera imaging.
• Data were analyzed using statistical comparisons of energy expenditure, lipolysis indices, and GE parameters.

Main Results:

• Mazindol administration (2 mg orally) did not significantly alter resting or exercise energy expenditure or lipolysis.
• A significant delay in gastric emptying was observed after mazindol administration (median GEt1/2: 230 min vs. 119 min for placebo).
• Mazindol reduced the rate and extent of solid meal emptying from the stomach, particularly in the later phase.

Conclusions:

• Mazindol does not appear to influence thermogenesis or lipolysis at the tested dosage.
• The significant inhibition of gastric emptying by mazindol suggests this effect may be a key factor in its weight-reducing capabilities.
• Further research into the gastrointestinal effects of mazindol is warranted.